[HTML][HTML] Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal

GES Batiha, HM Al-Kuraishy, AI Al-Gareeb… - …, 2023 - Springer
Abstract In coronavirus disease 2019 (Covid-19) era, neuroinflammation may develop due
to neuronal tropism of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) …

[PDF][PDF] Targeting of neuroinflammation by glibenclamide in Covid‑19: old weapon from arsenal

GES Batiha, HM Al‑kuraishy, AI Al‑Gareeb, M Alruwaili… - 2022 - d-nb.info
Abstract In coronavirus disease 2019 (Covid-19) era, neuroinflammation may develop due
to neuronal tropism of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) …

[PDF][PDF] Targeting of neuroinflammation by glibenclamide in Covid‑19: old weapon from arsenal

GES Batiha, HM Al‑kuraishy, AI Al‑Gareeb, M Alruwaili… - 2022 - scienceopen.com
Abstract In coronavirus disease 2019 (Covid-19) era, neuroinflammation may develop due
to neuronal tropism of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) …

Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal

GES Batiha, HM Al-Kuraishy… - …, 2023 - pubmed.ncbi.nlm.nih.gov
In coronavirus disease 2019 (Covid-19) era, neuroinflammation may develop due to
neuronal tropism of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) …

Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal.

GE Batiha, HM Al-Kuraishy, AI Al-Gareeb… - …, 2022 - europepmc.org
Abstract In coronavirus disease 2019 (Covid-19) era, neuroinflammation may develop due
to neuronal tropism of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) …

[HTML][HTML] Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal

GES Batiha, HM Al-kuraishy, AI Al-Gareeb… - …, 2023 - ncbi.nlm.nih.gov
Abstract In coronavirus disease 2019 (Covid-19) era, neuroinflammation may develop due
to neuronal tropism of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) …

Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal.

GE Batiha, HM Al-Kuraishy, AI Al-Gareeb… - …, 2022 - europepmc.org
In coronavirus disease 2019 (Covid-19) era, neuroinflammation may develop due to
neuronal tropism of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) …